Beau F - Search Results

1

Synthesis and in Vitro and in Vivo Evaluation of MMP-12 Selective Optical Probes.

Bordenave T, Helle M, Beau F, Georgiadis D, Tepshi L, Bernes M, Ye Y, Levenez L, Poquet E, Nozach H, Razavian M, Toczek J, Stura EA, Dive V, Sadeghi MM, Devel L. Bordenave T, et al. Among authors: beau f. Bioconjug Chem. 2016 Oct 19;27(10):2407-2417. doi: 10.1021/acs.bioconjchem.6b00377. Epub 2016 Sep 14. Bioconjug Chem. 2016. PMID: 27564088 Free PMC article.

2

Membrane type-1 matrix metalloprotease and stromelysin-3 cleave more efficiently synthetic substrates containing unusual amino acids in their P1' positions.

Mucha A, Cuniasse P, Kannan R, Beau F, Yiotakis A, Basset P, Dive V. Mucha A, et al. Among authors: beau f. J Biol Chem. 1998 Jan 30;273(5):2763-8. doi: 10.1074/jbc.273.5.2763. J Biol Chem. 1998. PMID: 9446583 Free article.

3

Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.

Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V. Vassiliou S, et al. Among authors: beau f. J Med Chem. 1999 Jul 15;42(14):2610-20. doi: 10.1021/jm9900164. J Med Chem. 1999. PMID: 10411481

4

Role of the S1' subsite glutamine 215 in activity and specificity of stromelysin-3 by site-directed mutagenesis.

Holtz B, Cuniasse P, Boulay A, Kannan R, Mucha A, Beau F, Basset P, Dive V. Holtz B, et al. Among authors: beau f. Biochemistry. 1999 Sep 14;38(37):12174-9. doi: 10.1021/bi990876m. Biochemistry. 1999. PMID: 10508422

5

Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.

Georgiadis D, Beau F, Czarny B, Cotton J, Yiotakis A, Dive V. Georgiadis D, et al. Among authors: beau f. Circ Res. 2003 Jul 25;93(2):148-54. doi: 10.1161/01.RES.0000081593.33848.FC. Epub 2003 Jun 12. Circ Res. 2003. PMID: 12805239

6

Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.

Matziari M, Beau F, Cuniasse P, Dive V, Yiotakis A. Matziari M, et al. Among authors: beau f. J Med Chem. 2004 Jan 15;47(2):325-36. doi: 10.1021/jm0308491. J Med Chem. 2004. PMID: 14711305

7

Phosphinic peptides as zinc metalloproteinase inhibitors.

Dive V, Georgiadis D, Matziari M, Makaritis A, Beau F, Cuniasse P, Yiotakis A. Dive V, et al. Among authors: beau f. Cell Mol Life Sci. 2004 Aug;61(16):2010-9. doi: 10.1007/s00018-004-4050-y. Cell Mol Life Sci. 2004. PMID: 15316651 Free PMC article. Review.

8

Dosing and scheduling influence the antitumor efficacy of a phosphinic peptide inhibitor of matrix metalloproteinases.

Dive V, Andarawewa KL, Boulay A, Matziari M, Beau F, Guerin E, Rousseau B, Yiotakis A, Rio MC. Dive V, et al. Among authors: beau f. Int J Cancer. 2005 Feb 20;113(5):775-81. doi: 10.1002/ijc.20459. Int J Cancer. 2005. PMID: 15499617

9

Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs.

Cuniasse P, Devel L, Makaritis A, Beau F, Georgiadis D, Matziari M, Yiotakis A, Dive V. Cuniasse P, et al. Among authors: beau f. Biochimie. 2005 Mar-Apr;87(3-4):393-402. doi: 10.1016/j.biochi.2004.09.025. Biochimie. 2005. PMID: 15781327 Review.

10

Development of selective inhibitors and substrate of matrix metalloproteinase-12.

Devel L, Rogakos V, David A, Makaritis A, Beau F, Cuniasse P, Yiotakis A, Dive V. Devel L, et al. Among authors: beau f. J Biol Chem. 2006 Apr 21;281(16):11152-60. doi: 10.1074/jbc.M600222200. Epub 2006 Feb 15. J Biol Chem. 2006. PMID: 16481329 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters